ClaimsFiler is reminding investors of Apollo Global Management, Inc. (NYSE: APO) with losses over $100,000 that they have until May 1, 2026, to file as lead plaintiff in a securities class action lawsuit. The lawsuit alleges that Apollo and its executives made false and misleading statements about the company's business relationship with Jeffrey Epstein, particularly regarding communications between its leaders and Epstein in the 2010s. This alleged entanglement caused significant reputational harm, making the company's public statements about its operations materially false and misleading.

Barclays analysts reacted to reports of Johnson Controls International (JCI) potentially divesting parts of its security business, noting that this development largely aligns with existing investor expectations. The divestment could lead to a 5% adjusted EPS dilution if proceeds are not reinvested, but it could also sharpen JCI's focus on its HVAC and data center businesses. Potential acquirers like Allegion, APi Group, and Honeywell could find these assets earnings-accretive depending on deal structure.

This article covers recent significant business events, including the departure of FedEx CFO John Dietrich and Critical Loop securing $26 million in Series A funding to address power grid bottlenecks. Additionally, Descartes introduced a new AI-driven platform with an agent named "René" to enhance fleet efficiency. These developments highlight major transitions in global logistics, industrial energy, and technological advancements for supply chain optimization.

Kimberly-Clark has announced its post-acquisition leadership structure and key organizational roles, which will take effect following its pending merger with Kenvue Inc. The deal, expected to close in the second half of 2026, will combine prominent brands like Listerine and Band-Aid with Cottonelle, Huggies, and Kleenex. The new entity will feature four business segments, each led by a regional president, while Mike Hsu will continue as chairman and CEO with a direct team reporting to him.

A post-approval study of Medtronic's IN.PACT AV DCB (drug-coated balloon) for end-stage kidney disease patients has demonstrated similar efficacy to its pivotal trial, with 70.2% of lesions remaining open at 12 months without reintervention or thrombosis, compared to 65.3% in the pivotal trial. This outcome addresses long-term safety concerns regarding paclitaxel-coated devices, which previously prompted an FDA requirement for extended monitoring. The FDA had reversed its warning about paclitaxel devices in 2023, indicating no increased risk of death.

Pennsylvania American Water (NYSE: AWK) has been awarded $25.9 million in PENNVEST funding for infrastructure improvements in Lackawanna and Lawrence counties. This funding includes a loan for the Griffin Dam rehabilitation and a grant and loan to replace approximately 603 lead-impacted service lines in New Castle. These projects aim to enhance dam safety and improve water quality for customers.

Pennsylvania American Water has secured over $25 million in PENNVEST funding, including grants and low-interest loans, for critical infrastructure projects in Lackawanna and Lawrence counties. The funding will support the rehabilitation of Griffin Dam to meet current safety standards and replace approximately 603 lead and galvanized lead-impacted water service lines in New Castle. These initiatives aim to ensure high-quality, reliable, and safe water services for customers, aligning with the company's commitment to environmental standards and lead elimination.

Wells Fargo has maintained its Overweight rating on Wynn Resorts (WYNN) but lowered its price target from $147.00 to $144.00. Despite this adjustment, the stock is considered undervalued by GuruFocus with a GF Value™ of $120.47 against a current price of $106.84, and it holds a strong GF Score™ of 82/100, indicating good fundamentals. Investors are advised to consider the high P/E ratio and financial strength.

Bank of America has increased its price target for J.B. Hunt Transport Services (NASDAQ:JBHT) to $250.00 from $225.00, maintaining a "buy" rating after the company exceeded Q1 earnings and revenue expectations. Several other analysts have also raised their price targets, contributing to a "Moderate Buy" consensus. Despite high valuation metrics and recent insider selling, J.B. Hunt's stock has seen positive movement, driven by strong quarterly results and positive macro sentiment regarding freight market recovery.

Advanced Micro Devices (AMD) stock reached an all-time high on Thursday, extending its winning streak to 12 consecutive days. This impressive run follows closely on the heels of Nvidia's recent gains, highlighting AMD's robust performance in the market. The article questions whether AMD can maintain this momentum.